STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] DocuSign, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

DocuSign director Teresa Briggs received a grant of 729 restricted stock units on 08/29/2025, each RSU representing the contingent right to one share of DocuSign common stock. The reported transactions show 729 RSUs acquired at a reported price of $0 and an increase in directly held common stock to 9,534 shares. Following the grant, the reporting person beneficially owns 2,187 RSUs that convert into common shares if they vest. The RSUs have a vest commencement date of May 29, 2025 and vest in equal quarterly installments over one year, with the fourth installment accelerating to the earlier of the company’s next annual meeting or the one-year anniversary, subject to continued service. The RSUs do not expire.

Positive
  • Director received 729 RSUs on 08/29/2025, clearly disclosed
  • Vesting schedule provided: commencement date May 29, 2025 with equal quarterly installments and an acceleration clause
Negative
  • None.

Insights

TL;DR: Routine director equity grant with time-based vesting; typical for aligning director interests with shareholders.

The Form 4 reports a time-based grant of 729 RSUs to a director, exercised at a $0 reporting price and subject to quarterly vesting over one year with a standard acceleration clause tied to the next annual meeting or one-year anniversary. The filing is procedural and discloses change in beneficial ownership to 9,534 direct shares and 2,187 RSUs held post-transaction. No unusual terms, expirations, or derivative instruments beyond RSUs are reported. Impact on governance oversight is minimal based solely on this disclosure.

TL;DR: Short-term, time-vested equity awarded; modest absolute size relative to typical director grants.

The disclosure shows 729 restricted stock units granted with vesting beginning May 29, 2025 and quarterly vesting over one year, and a reported $0 price per unit, indicating stock-settled RSUs. Post-grant holdings include 2,187 RSUs. The grant structure is straightforward: four quarterly installments with the final installment accelerated to the earlier of the next annual meeting or one-year anniversary, subject to continued service. No cash exercises or option exercises are present.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Briggs Teresa

(Last) (First) (Middle)
C/O DOCUSIGN, INC.
221 MAIN STREET, SUITE 800

(Street)
SAN FRANCISCO CA 94105

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
DOCUSIGN, INC. [ DOCU ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/29/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/29/2025 M 729 A $0 9,534 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 08/29/2025 M 729 (2) (3) Common Stock 729 $0 2,187 D
Explanation of Responses:
1. Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
2. The RSUs have a vest commencement date of May 29, 2025 and will vest in equal quarterly installments over one year, provided that the fourth quarterly installment shall vest in full on the earlier of (i) the date of the Company's next annual meeting of stockholders and (ii) the one year anniversary of the grant, in each case, subject to the Reporting Person being a service provider through each such date.
3. The RSUs do not expire; they either vest or are canceled prior to vesting date.
Remarks:
/s/ Derrick Chapman, Attorney-in-fact 09/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Teresa Briggs report on DocuSign (DOCU) Form 4?

The Form 4 reports a grant of 729 restricted stock units to Teresa Briggs on 08/29/2025, increasing her directly held common stock to 9,534 shares and her RSU holdings to 2,187.

What is the vesting schedule for the RSUs reported on DOCU Form 4?

The RSUs have a vesting commencement date of May 29, 2025 and vest in equal quarterly installments over one year, with the fourth installment accelerating to the earlier of the company’s next annual meeting or the one-year anniversary, subject to continued service.

At what price were the RSUs reported on the Form 4 for DOCU?

The RSUs and the reported common stock transaction are shown with a $0 price on the Form 4.

Do the RSUs reported on DOCU Form 4 expire?

According to the Form 4 explanation, the RSUs do not expire; they either vest or are canceled prior to the vesting date.
Docusign

NASDAQ:DOCU

DOCU Rankings

DOCU Latest News

DOCU Latest SEC Filings

DOCU Stock Data

13.48B
199.05M
0.98%
89.07%
3.32%
Software - Application
Services-prepackaged Software
Link
United States
SAN FRANCISCO